Losartan Potassium Tablet, Film Coated
Product Images NDC 63187-808

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 63187-808). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (8ca0c9d3 3a50 4efe 92df 30a0c50d48a7 01)

Chemical structure of losartan potassium, showing the molecular arrangement including rings and side chains with potassium ion.*

FDA Label Image

Figure 1 (8ca0c9d3 3a50 4efe 92df 30a0c50d48a7 02)

A line graph comparing the percentage of patients with a primary endpoint over 66 study months for Losartan Potassium and Atenolol. The graph shows the progression of risk with Atenolol indicated by a dotted line and Losartan Potassium by a solid line, with a noted adjusted risk reduction of 13% and a p-value of 0.021.*

FDA Label Image

Figure 2 (8ca0c9d3 3a50 4efe 92df 30a0c50d48a7 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months for Atenolol and Losartan Potassium. The graph shows a lower percentage of stroke occurrences in patients treated with Losartan Potassium compared to Atenolol, with an adjusted risk reduction of 25% (p=0.001).*

FDA Label Image

Figure 3 (8ca0c9d3 3a50 4efe 92df 30a0c50d48a7 04)

A forest plot comparing Losartan Potassium and Atenolol event rates for Primary Composite and Stroke (Fatal/Non-fatal) outcomes across various patient subgroups including age, gender, race, ischemic heart disease (ISH), diabetes, and cardiovascular disease (CVD) history. The plot displays hazard ratios with 95% confidence intervals indicating relative risks favoring either Losartan Potassium or Atenolol treatment.*

FDA Label Image

Losartan (8ca0c9d3 3a50 4efe 92df 30a0c50d48a7 05)

A line graph comparing the percentage of patients with an event over 48 months between two groups: one receiving Losartan Potassium and the other receiving a placebo. The graph shows a lower event rate for Losartan Potassium with a noted risk reduction of 16.1% and a p-value of 0.022, indicating statistical significance.*

FDA Label Image

63187-808 (8ca0c9d3 3a50 4efe 92df 30a0c50d48a7 08)

Losartan Potassium 100 mg tablets label by Proficient Rx LP shows a package of 90 oral film-coated tablets. Each white to off-white, round, convex tablet is debossed with 'S' on one side and '113' on the other. Manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd., China. The label includes storage instructions and lot, expiration, and serial number placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.